Furthermore, the TOX expression in CD8+ effector T cells was induced by Treg-mediated IL-2/STAT5 activation, while CD8+ tissue-resident T cells showed no corresponding changes in tumor samples (Figure 7I). The gene discussed is CD8A; the disease is neoplasm.